Hunter Associates Investment Management’s Novo Nordisk NVO Stock Holding History

Hunter Associates Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951K	Buy	19,899 +401	+2%	+$17.2K	0.11%	151
2026 Q1	$716K	Hold	19,498	–	–	0.09%	161
2025 Q4	$989K	Sell	19,498 -1,224	-6%	-$62.6K	0.13%	135
2025 Q3	$1.15M	Sell	20,722 -1,201	-5%	-$70.3K	0.16%	117
2025 Q2	$1.52M	Hold	21,923	–	–	0.22%	100
2025 Q1	$1.52M	Buy	21,923 +45	+0.2%	+$3.72K	0.23%	94
2024 Q4	$1.88M	Buy	21,878 +88	+0.4%	+$9.52K	0.29%	84
2024 Q3	$2.6M	Hold	21,790	–	–	0.4%	61
2024 Q2	$3.11M	Sell	21,790 -4,106	-16%	-$544K	0.52%	40
2024 Q1	$3.33M	Buy	25,896 +160	+0.6%	+$19K	0.56%	42
2023 Q4	$2.66M	Hold	25,736	–	–	0.49%	50
2023 Q3	$2.34M	Buy	25,736 +262	+1%	+$23.1K	0.47%	52
2023 Q2	$2.06M	Hold	25,474	–	–	0.4%	60
2023 Q1	$2.03M	Hold	25,474	–	–	0.43%	60
2022 Q4	$1.72M	Hold	25,474	–	–	0.42%	64
2022 Q3	$1.27M	Hold	25,474	–	–	0.33%	75
2022 Q2	$1.42M	Buy	25,474 +1,474	+6%	+$81.8K	0.35%	71
2022 Q1	$1.33M	Hold	24,000	–	–	0.43%	50
2021 Q4	$1.34M	Hold	24,000	–	–	0.38%	54
2021 Q3	$1.15M	Hold	24,000	–	–	0.37%	57
2021 Q2	$1M	Sell	24,000 -1,426	-6%	-$55.3K	0.31%	57
2021 Q1	$857K	Buy	25,426 +800	+3%	+$28.5K	0.2%	88
2020 Q4	$860K	Buy	24,626 +2,426	+11%	+$83.9K	0.21%	85
2020 Q3	$771K	Hold	22,200	–	–	0.21%	88
2020 Q2	$727K	Hold	22,200	–	–	0.22%	89
2020 Q1	$668K	Hold	22,200	–	–	0.26%	79
2019 Q4	$642K	Sell	22,200 -600	-3%	-$16.6K	0.2%	93
2019 Q3	$589K	Hold	22,800	–	–	0.2%	88
2019 Q2	$582K	Hold	22,800	–	–	0.2%	86
2019 Q1	$596K	Hold	22,800	–	–	0.21%	89
2018 Q4	$525K	Hold	22,800	–	–	0.21%	87
2018 Q3	$537K	Sell	22,800 -1,250	-5%	-$30.5K	0.19%	95
2018 Q2	$555K	Sell	24,050 -250	-1%	-$5.94K	0.2%	94
2018 Q1	$598K	Hold	24,300	–	–	0.22%	85
2017 Q4	$652K	Hold	24,300	–	–	0.24%	80
2017 Q3	$585K	Hold	24,300	–	–	0.23%	84
2017 Q2	$521K	Buy	24,300 +2,470	+11%	+$49.8K	0.21%	91
2017 Q1	$374K	Hold	21,830	–	–	0.16%	113
2016 Q4	$391K	Hold	21,830	–	–	0.17%	103
2016 Q3	$454K	Sell	21,830 -250	-1%	-$6.2K	0.2%	103
2016 Q2	$594K	Hold	22,080	–	–	0.26%	80
2016 Q1	$598K	Hold	22,080	–	–	0.27%	78
2015 Q4	$641K	Sell	22,080 -120	-0.5%	-$3.32K	0.28%	75
2015 Q3	$602K	Sell	22,200 -1,650	-7%	-$46.7K	0.28%	82
2015 Q2	$653K	Sell	23,850 -2,800	-11%	-$78.7K	0.27%	87
2015 Q1	$711K	Hold	26,650	–	–	0.28%	83
2014 Q4	$564K	Hold	26,650	–	–	0.22%	94
2014 Q3	$635K	Buy	26,650 +1,500	+6%	+$34.5K	0.25%	87
2014 Q2	$581K	Hold	25,150	–	–	0.23%	89
2014 Q1	$574K	Sell	25,150 -15,250	-38%	-$325K	0.23%	90
2013 Q4	$746K	Buy	40,400 +1,250	+3%	+$21.8K	0.29%	77
2013 Q3	$662K	Buy	39,150 +7,950	+25%	+$134K	0.28%	78
2013 Q2	$484K	Buy	+31,200	New	+$519K	0.18%	111

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Hunter Associates Investment Management's NVO Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Novo Nordisk (NVO) stake by 2.1% in Q2 2026, buying an estimated $17.2K and bringing the position to 19,899 shares worth $951K. The position accounts for 0.11% of the portfolio, ranked #151.

Hunter Associates Investment Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.33M in Q1 2024. 875 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hunter Associates Investment Management held 19,899 shares of Novo Nordisk worth $951K as of Q2 2026.
Hunter Associates Investment Management bought 401 Novo Nordisk shares in Q2 2026, an estimated $17.2K.
Novo Nordisk made up 0.11% of Hunter Associates Investment Management's portfolio in Q2 2026, its #151 holding.
Hunter Associates Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
Hunter Associates Investment Management's Novo Nordisk position peaked at $3.33M in Q1 2024.
875 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.